Sanofi CFO says stock price pummelling grossly overdone
FRANKFURT (Reuters) – Sanofi’s finance chief said on Wednesday that a decline in the French company’s share price in response to litigation threats and a cancer drug development setback was…
FRANKFURT (Reuters) – Sanofi’s finance chief said on Wednesday that a decline in the French company’s share price in response to litigation threats and a cancer drug development setback was…